---
figid: PMC9043318__fimmu-13-868229-g002
figtitle: miRNAs Can Affect Intestinal Epithelial Barrier in Inflammatory Bowel Disease
organisms:
- Escherichia coli
- Bacteroides fragilis
- Mangifera indica
- Cinnamomum verum
- Clostridium butyricum
- Prevotella sp.
- Saccharomyces boulardii nom. inval.
- Sinomenium acutum
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Caenorhabditis elegans
pmcid: PMC9043318
filename: fimmu-13-868229-g002.jpg
figlink: /pmc/articles/PMC9043318/figure/f2/
number: F2
caption: miRNAs control NF-κB signaling pathway in IBD. miR-15, miR-16, and miR-206
  downregulate A2aAR or A3AR expression, further inhibiting NF-κB and the level of
  IL-8 and IFN-γ in UC. miR-323b-5p and miR-146a target and inhibit the TLR4/MyD88/NF-κB
  signaling pathway. miR-375 competitively inhibits TLR4 expression, further alleviating
  the generation of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-8) and
  the deterioration of intestinal mucus (i.e., ZO-1 and occluding downregulation).
  miR-125b and miR-223 inhibit TLR4/MyD88/NF-κB signaling pathway through respectively
  downregulating TRAF6 and IKKα in IBD.
papertitle: miRNAs Can Affect Intestinal Epithelial Barrier in Inflammatory Bowel
  Disease.
reftext: Xiangjun Xiao, et al. Front Immunol. 2022;13:868229.
year: '2022'
doi: 10.3389/fimmu.2022.868229
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.
keywords: miRNA | inflammatory bowel disease | intestinal epithelial barrier | gene
  targets | signaling pathways
automl_pathway: 0.9664834
figid_alias: PMC9043318__F2
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC9043318__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9043318__fimmu-13-868229-g002.html
  '@type': Dataset
  description: miRNAs control NF-κB signaling pathway in IBD. miR-15, miR-16, and
    miR-206 downregulate A2aAR or A3AR expression, further inhibiting NF-κB and the
    level of IL-8 and IFN-γ in UC. miR-323b-5p and miR-146a target and inhibit the
    TLR4/MyD88/NF-κB signaling pathway. miR-375 competitively inhibits TLR4 expression,
    further alleviating the generation of pro-inflammatory cytokines (TNF-α, IL-1β,
    IL-6, and IL-8) and the deterioration of intestinal mucus (i.e., ZO-1 and occluding
    downregulation). miR-125b and miR-223 inhibit TLR4/MyD88/NF-κB signaling pathway
    through respectively downregulating TRAF6 and IKKα in IBD.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mir206
  - Nfkb1
  - Tnf
  - Il1b
  - Il6
  - Mir146a
  - Myd88
  - Chuk
  - Tlr4
  - Mir223
  - Mir375
  - MIR206
  - ADRA2A
  - ADORA3
  - NFKB1
  - NFKBIA
  - TNF
  - IL1B
  - CXCL8
  - IL6
  - MIR146A
  - MYD88
  - CHUK
  - TLR4
  - MIR223
  - MIR375
  - IRF6
  - Adora2a
  - Adra2a
  - Adora3
  - Cxcl15
  - Mir146
  - Fas
  - F630028O10Rik
---
